Clinical trials
Phase 2 Hodgkin Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 6 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Italiana Linfomi - ETS | 5 |
| Fred Hutchinson Cancer Center | 4 |
| Bristol-Myers Squibb | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Seagen Inc. | 2 |
| ADC Therapeutics S.A. | 1 |
| Amgen | 1 |
| Armando Santoro, MD | 1 |
| Centro di Riferimento Oncologico - Aviano | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 26 |
| Multiple Myeloma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Recurrence | 5 |
| Waldenstrom Macroglobulinemia | 5 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.